Legend Biotech (LEGN) Long-Term Deferred Tax (2019 - 2021)

Legend Biotech's Long-Term Deferred Tax history runs 3 years deep, the most recent figure standing at $22.8 million for Q4 2021.

• Quarterly Long-Term Deferred Tax fell 25.98% year-over-year to $22.8 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $22.8 million (down 25.98% YoY) and the FY2021 annual result came in at $22.8 million, down 25.98% from the prior year.
• Long-Term Deferred Tax was $22.8 million for Q4 2021 at Legend Biotech, down from $30.8 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $30.8 million in Q4 2020 and bottomed at $5.7 million in Q4 2019.
• A 3-year average of $19.8 million and a median of $22.8 million in 2021 frame the typical range for Long-Term Deferred Tax.
• Annual changes were most pronounced in 2020 — Long-Term Deferred Tax jumped 438.86% — and 2021, when it slipped 25.98%.
• Legend Biotech's Long-Term Deferred Tax stood at $5.7 million in 2019, then soared by 438.86% to $30.8 million in 2020, then declined by 25.98% to $22.8 million in 2021.
• Business Quant data shows LEGN's Long-Term Deferred Tax at $22.8 million in Q4 2021, $30.8 million in Q4 2020, and $5.7 million in Q4 2019.